We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Itaconix Plc | LSE:ITX | London | Ordinary Share | GB00BPK3YZ68 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 153.00 | 146.00 | 160.00 | 153.00 | 148.00 | 153.00 | 0.00 | 08:00:12 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Chemicals & Chem Preps, Nec | 5.6M | -2.46M | -0.1826 | -8.38 | 20.63M |
Date | Subject | Author | Discuss |
---|---|---|---|
15/10/2019 07:50 | Last trade yesterday was above offer price so any early buys and we will see a tick up. Worth remembering we are already partnered with the biggest players in the chemicals market:Odour control: Croda, world number 2 in the segment Non-phosphate detergents: Nouryon, world number 1 in the segment Hair-care / personal care: Nouryon, world number 1 in the segmentAny whiff of good news and this could move quickly as we have seen before. | parob | |
15/10/2019 07:10 | Previously the share price was explained by Woodford sale, now spreadex. I think those things have an effect, but the cash call overhang here and lack of newslfow also a big impact. I bought in at 1.50 and will top up at that level if opportunity arises, but am wary of a placement at a discount. | the ghost who walks | |
15/10/2019 07:10 | Let us hope for a quick bounce back Topped up heavily yesterday | the patient investor | |
14/10/2019 22:15 | 31m value for 4.37m | lukehold | |
14/10/2019 22:14 | Market InsightsThe global Hair Gel market is expected to reach USD 1.9 billion by 2023, witnessing a healthy CAGR of 3.9% during the forecast period. Europe holds the major share in global Hair Gel market with more than 33%. About 393 million units of Hair Gel consumed globally in 2017, which is growing at a stable rate.Europe recorded a slow growth rate of 2% during the forecast period owing to mature nature of the market. At present Asia-pacific accounts for more than 26% of the market share at a constant value, which is followed by South America. Innovation such as convenient pack size and natural ingredients in the product fueled the Hair Gel market growth.Natural EverywhereIncreased consumer awareness about the benefits of natural and organic ingredients in the hair care products has fueled the demand for active ingredients. | lukehold | |
14/10/2019 20:11 | Global partner Nouryon will be promoting their Amaze share price (Itaconix) polymer at Cosmetorium in Barcelona next week - “Creating modern and natural styles with Amaze SP” Date: 23/10/2019 Synopsis In recent years, the development of a new styling trend has become much more evident in the world around us. Gone are the days of elaborate styles, requiring hard holding films to lock in the look that took hours to create. The latest trends now call for a natural or nude look; styles are minimalistic and give a “low key” look, accentuating each individual’s natural hair type. While this seems easy enough to follow, it becomes more challenging when formulators must use synthetic polymers developed for traditionally elaborate styles to create something which will deliver a weightless, invisible style. Amaze™ share price polymer is a new entry into the hair styling market designed to offer consumers a more natural hold. It can be formulated into a variety of hair styling products ranging from mousses to creams and even some sprays. Being derived from a natural source and manufactured using an extremely eco-conscious process, Amaze share price is a sustainable styling polymer which performs in a manner not often seen by formulators. While it can be compared to some of the synthetic or partially synthetic offerings in the market, Amaze™ share price brings with it several benefits that truly differentiate it from the competition. | parob | |
14/10/2019 20:09 | Can see this bouncing hard any day now. Strong support around this level. | parob | |
14/10/2019 19:12 | They are traders NOT investors. Should be cleared this week imo | jungmana | |
14/10/2019 13:44 | I think spreadex are almost out. Could see a quick double from here short term | jungmana | |
14/10/2019 12:43 | No one said they are breakeven. That's is expected next year. | jungmana | |
14/10/2019 12:41 | Seeing increasing revenues would be a good and essential start, it means you have a business, and it might make the difference between diluting equity, or raising debt. | lefrene | |
14/10/2019 12:23 | Generating revenue is fine but it's profit they need. They are nowhere near breakeven | pictureframe | |
14/10/2019 12:13 | A fund raise may not be be necessary as they have enough funds for next 9 months and are expected to generate revenues of about GBP1m this half of 2019. 2020 expectation is revenues of GBP3.5m | jungmana | |
14/10/2019 12:10 | Thanks for the link Parob, I guess the company needs to show us the money? Are they getting contracts for useful wanted products, or are they still trying to come up with something that will sell in volume? I guess there are as yet no new big contracts or else there would be an rns. Although I remain hopeful, ITX is to me looking very much like the usual AiM chancer. | lefrene | |
14/10/2019 11:53 | The share price was 2.2p when this analyst interview was filmed on the 27/6/19. The analyst said that global peers with similar technologies are valued 3-5 times. From 2 mins 40 secs. hTTps://tinyurl.com/ | parob | |
14/10/2019 11:36 | I meant hold off fundraising | ewanwhose | |
14/10/2019 11:34 | If things are going well, it would make sense to hold off until after the TU which should be February. The market will then have the latest figures and a clearer view of when breakeven might be.We are hopefully shipping regularly to existing customers and new ones may have come on stream (even without an RNS) so the figures could be quite good.While I'm in optimistic mood, could we even be in a position (based the order position at the time) for the next funding to be debt rather than equity? Would probably still need another tranche of equity later but at a higher price so less dilution. | ewanwhose | |
14/10/2019 11:32 | I can't see them selling out for under 15p personally. They have an IP moat, a growing revenue stream, and global customers. 15p would still be pocket change for a chemicals major. NAI | cyberbub | |
14/10/2019 11:25 | Or if they do have something really useful, will a major customer simply buy them out while they are flat on the floor? | lefrene | |
14/10/2019 11:11 | No of course not, but as I say I still wouldn't expect a cash raise until they are down to 3-4 months cash (ie. Approx Feb?). Anyway who knows I don't have a crystal ball and neither does anyone else :-) | cyberbub | |
14/10/2019 10:58 | Small 60k top up for me. Very hard to buy | jungmana | |
14/10/2019 10:04 | Cyberbub, are they likely to leave it last minute to raise though? | rhatton | |
14/10/2019 09:56 | Wrong picture frame. They had £1.5M left at the end of June and central costs are a little over £2M p.a. So that means 9 months of cash left - plus growing operational profits. So they should have approx enough cash to reach late spring 2020. I don't expect a cash raise until some way after Xmas, and hopefully it won't be more than £1.5M. Even in the worst case of raising at 1.5p (which seems pretty unlikely to me) that's only 100M shares extra, OK not great but not disastrous.NAI | cyberbub | |
14/10/2019 09:04 | They need to get the cash raise out of the way. There have been no further contract wins announced and time is running out. | pictureframe |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions